A transmembrane form of the prion protein in neurodegenerative disease.
about
The great escape: viral strategies to counter BST-2/tetherinThe reticulons: a family of proteins with diverse functionsMagnesium inhibits spontaneous and iron-induced aggregation of alpha-synucleinCytosolic quality control of mislocalized proteins requires RNF126 recruitment to Bag6Pseudoknots in prion protein mRNAs confirmed by comparative sequence analysis and pattern searchingPrionsA novel human disease with abnormal prion protein sensitive to proteaseThe delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiologyNMR Structure of the Human Prion Protein with the Pathological Q212P Mutation Reveals Unique Structural FeaturesInteractions between the Conserved Hydrophobic Region of the Prion Protein and Dodecylphosphocholine MicellesCell death in the nervous systemLipids in the assembly of membrane proteins and organization of protein supercomplexes: implications for lipid-linked disordersNeurotoxicity of prion peptides mimicking the central domain of the cellular prion proteinMembrane topology and cell surface targeting of microsomal epoxide hydrolase. Evidence for multiple topological orientationsEarly Vertebrate Evolution of the Host Restriction Factor TetherinCounteraction of the multifunctional restriction factor tetherinComparative genomic analysis of prion genesPrion protein: evolution caught en routeCellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein.Lethal recessive myelin toxicity of prion protein lacking its central domain.Reduced translocation of nascent prion protein during ER stress contributes to neurodegeneration.Live imaging of prions reveals nascent PrPSc in cell-surface, raft-associated amyloid strings and websDetermination of solution conformations of PrP106-126, a neurotoxic fragment of prion protein, by 1H NMR and restrained molecular dynamics.Utilizing NMR and EPR spectroscopy to probe the role of copper in prion diseases.Molecular dynamics simulation of human prion protein including both N-linked oligosaccharides and the GPI anchor.Copper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP. Effect of protein age and deamidation.Yeast genes controlling responses to topogenic signals in a model transmembrane protein.Synthetic miniprion PrP106.The signal peptide of the rat corticotropin-releasing factor receptor 1 promotes receptor expression but is not essential for establishing a functional receptor.Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway.Functional depletion of mahogunin by cytosolically exposed prion protein contributes to neurodegenerationMolecular distinction between pathogenic and infectious properties of the prion protein.Spontaneous generation of rapidly transmissible prions in transgenic mice expressing wild-type bank vole prion protein.Selective processing and metabolism of disease-causing mutant prion proteins.Frequent missense and insertion/deletion polymorphisms in the ovine Shadoo gene parallel species-specific variation in PrP.Immunopurification of pathological prion protein aggregatesUnexpected tolerance of alpha-cleavage of the prion protein to sequence variationsCellular biology of prion diseases.Signal sequence insufficiency contributes to neurodegeneration caused by transmembrane prion protein.Cell type-specific neuroprotective activity of untranslocated prion protein.
P2860
Q21090506-7BC2E50C-AC59-4589-9A99-7EFB76E326B4Q21184131-85F2B080-F923-46A5-B86C-D3E6D1A7A8CCQ24292317-B9045ABF-C880-4FD6-9E20-926D9F42FAE0Q24300029-7971CD32-B8DA-4701-B0B9-7C89C7422EABQ24624652-F06BB9BF-6EFC-45D9-884E-ACD607195EDFQ24633319-09D19C7A-2A35-4B60-B0A7-5C415A1150E4Q24648865-80F543B5-92AD-421C-8C27-142BF19CE490Q27015793-71D1C27E-BE23-46DB-80C3-C0DCD8BA37BEQ27663617-794EBDC4-C7D4-4CAB-AD71-E1FE268A1778Q27675872-42127AD7-4941-4EEB-8781-314AE5CD8863Q28269343-FE1F5EF3-9B4C-480C-8558-DCE59329E9B2Q28386214-44337688-1625-43BC-9B0D-C5C4CABF4EFDQ28535083-0B21B5F8-60FE-4ED2-8C95-C93B388B323CQ28582020-A59FAE28-4C03-4733-9B92-8006C4243EB4Q28607463-2B4FBB11-E898-472E-AB26-C1EF7E07C8A9Q28659945-7303F0FC-F1BF-4B8A-836E-BA6FB387A716Q28763768-F0710BD5-6E06-4D05-80AB-6153586C4FEDQ28776299-EC3896B2-C586-455E-A1B8-866756E26A9EQ30032293-609D2C36-A76B-4BCA-97CB-13CD76F4683FQ30478899-22E0B72C-C0EB-4311-BE48-EC9BD0C15CBFQ30483989-876C1FF7-113B-4169-9F77-D04CECC01923Q30570683-5D9A1A05-371C-4FB0-9C4B-948CEDB7F9AEQ30585001-3F633DF9-C28D-46B5-866F-792188B56834Q30593594-F938B96A-E1B2-4DC1-BFCB-75EEAAA58F95Q30616807-D7FA51F3-6D0A-401B-B58A-EB53F5D7A740Q30881188-DF040CA9-26F8-4452-8889-0653D0A1DE82Q31048364-8EF4166F-78A9-4392-9F94-E57422E1E8B5Q32129400-2644CD13-0138-430B-AAF0-C07242C9686CQ33215289-603F079B-236D-4A27-B5B3-0845442D7EAAQ33264756-4255AAF2-8B64-475E-9C43-B8891AFE017BQ33289413-1286A3AF-379E-4179-94D7-978D64D64098Q33338476-8A7D5ACE-795D-4A1E-ACD2-FE8372BF3273Q33454462-6DA76EA1-2F41-4F05-89B1-DDE4ED979746Q33471412-C8821F16-5D3A-4CEB-B692-0206B1E0F94DQ33490984-00EE26F7-1635-45E1-97F8-9D886FD139D5Q33516017-AB60D718-6E04-4CF4-8DDD-C2AF36DBFE7BQ33531737-9F91795D-4182-42A5-987F-C1BEDC4A2CF1Q33558398-02D33207-BC26-4DA4-9C71-F49D5196AA02Q33689595-B7BCDA32-C075-46A4-AE6B-D86591E85CB9Q33742065-126B51B9-FC6B-458C-99ED-BC34EA847413
P2860
A transmembrane form of the prion protein in neurodegenerative disease.
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
A transmembrane form of the prion protein in neurodegenerative disease.
@ast
A transmembrane form of the prion protein in neurodegenerative disease.
@en
A transmembrane form of the prion protein in neurodegenerative disease.
@nl
type
label
A transmembrane form of the prion protein in neurodegenerative disease.
@ast
A transmembrane form of the prion protein in neurodegenerative disease.
@en
A transmembrane form of the prion protein in neurodegenerative disease.
@nl
prefLabel
A transmembrane form of the prion protein in neurodegenerative disease.
@ast
A transmembrane form of the prion protein in neurodegenerative disease.
@en
A transmembrane form of the prion protein in neurodegenerative disease.
@nl
P2093
P50
P921
P1433
P1476
A transmembrane form of the prion protein in neurodegenerative disease.
@en
P2093
Lingappa VR
Mastrianni JA
Tremblay P
P304
P356
10.1126/SCIENCE.279.5352.827
P407
P577
1998-02-01T00:00:00Z